Skip to main content
Top
Published in: European Journal of Ageing 3/2020

Open Access 01-09-2020 | Original Investigation

Purchases of medicines among community-dwelling older people: comparing people in the last 2 years of life and those who lived at least 2 years longer

Authors: Jutta Pulkki, Mari Aaltonen, Jani Raitanen, Pekka Rissanen, Marja Jylhä, Leena Forma

Published in: European Journal of Ageing | Issue 3/2020

Login to get access

Abstract

While it is known that those who are living their last years are frequent users of social and health services, research about medicines at the end of life is scarce. We examined whether the proportions of purchasers and the types of prescription medicines purchased during a 2-year period differed between community-dwelling old people who died (decedents) in 2002, 2006 or 2011 and old people who lived at least 2 years longer (survivors) in Finland. We also examined how those differences changed over time. The study population was identified from nationwide registers and consisted of 174,097 community-dwelling people who were 70 years of age or older. Of these, 81,893 were decedents and 92,204 survivors. Data on purchases of medicines were gathered from the Finnish prescription database. Along with descriptive analyses, binary logistic regression analysis was used to find the association between decedent status and the purchase of medicines in general and different categories of medicines in particular. Almost all community-dwelling decedents and survivors purchased medicines at least once during the 2-year period. Over time, the proportion of purchasers increased in both groups but especially among survivors, thereby reducing the differences between the groups. However, the probability of purchasing medicines in general and different categories of medicine in particular remained significantly higher for decedents than for survivors after adjustments. This study shows that purchases of medication are concentrated at the end of life, as is the use of social and health services. However, the differences between decedents and survivors diminish over time.
Appendix
Available only for authorised users
Literature
go back to reference Aaltonen M, Pulkki J, Forma L, Raitanen J, Rissanen P, Jylhä M (2016) The cost and reimbursements of drugs for Alzheimer disease multiplied in the last years of life. Lääkärilehti 71(43):2723–2729 Aaltonen M, Pulkki J, Forma L, Raitanen J, Rissanen P, Jylhä M (2016) The cost and reimbursements of drugs for Alzheimer disease multiplied in the last years of life. Lääkärilehti 71(43):2723–2729
go back to reference Barat I, Andreasen F, Damsgaard M (2000) The consumption of medicines by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509CrossRef Barat I, Andreasen F, Damsgaard M (2000) The consumption of medicines by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509CrossRef
go back to reference Bell S, Klaukka T, Ahonen J, Hartikainen S (2009) National utilization of transdermal fentanyl among community-dwelling older people in Finland. Am J Geriatr Pharmacother 17:355–361CrossRef Bell S, Klaukka T, Ahonen J, Hartikainen S (2009) National utilization of transdermal fentanyl among community-dwelling older people in Finland. Am J Geriatr Pharmacother 17:355–361CrossRef
go back to reference Blomgren J, Einiö E (2015) The deinstitutionalisation of old age care: its association with other long-term care services and outpatient medical expenses in 2000–2013. Yhteiskuntapolitiikka 80(4):334–348 Blomgren J, Einiö E (2015) The deinstitutionalisation of old age care: its association with other long-term care services and outpatient medical expenses in 2000–2013. Yhteiskuntapolitiikka 80(4):334–348
go back to reference Crimmins EM, Beltrán-Sánchez H (2011) Mortality and morbidity trends: is there compression of morbidity? J Gerontol Ser B 1(1):75–86CrossRef Crimmins EM, Beltrán-Sánchez H (2011) Mortality and morbidity trends: is there compression of morbidity? J Gerontol Ser B 1(1):75–86CrossRef
go back to reference Crockett A (2005) Use of prescription drugs: rising or declining? Nurs Clin North Am 40:33–49CrossRef Crockett A (2005) Use of prescription drugs: rising or declining? Nurs Clin North Am 40:33–49CrossRef
go back to reference Cruz-Jentoft AJ, Boland B, Rexach L (2012) Drug therapy optimization at the end of life. Drugs Aging 29(6):511–521CrossRef Cruz-Jentoft AJ, Boland B, Rexach L (2012) Drug therapy optimization at the end of life. Drugs Aging 29(6):511–521CrossRef
go back to reference Curtin D, O’Mahony D, Gallagher P (2018) Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing 47:749–753CrossRef Curtin D, O’Mahony D, Gallagher P (2018) Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing 47:749–753CrossRef
go back to reference Elliot R (2006) Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res 36(1):58–66CrossRef Elliot R (2006) Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res 36(1):58–66CrossRef
go back to reference Fimea (2016) Finnish Statistics on Medicines Finnish medicines agency Fimea and social insurance institution Erweco, Helsinki Fimea (2016) Finnish Statistics on Medicines Finnish medicines agency Fimea and social insurance institution Erweco, Helsinki
go back to reference Forma L (2011) Health and social service use among older people: the last two years of life. Dissertation, University of Tampere Forma L (2011) Health and social service use among older people: the last two years of life. Dissertation, University of Tampere
go back to reference Forma L, Rissanen P, Noro A, Raitanen J, Jylhä M (2007) Health and social service use among old people in the last 2 years of life. Eur J Ageing 4:145–154CrossRef Forma L, Rissanen P, Noro A, Raitanen J, Jylhä M (2007) Health and social service use among old people in the last 2 years of life. Eur J Ageing 4:145–154CrossRef
go back to reference Giron M, Claesson C, Thorslund M, Oke T, Winbland B, Fastbom J (1999) Drug use patterns in a very elderly population: a seven-year review. Clin Drug Investig 17(5):389–398CrossRef Giron M, Claesson C, Thorslund M, Oke T, Winbland B, Fastbom J (1999) Drug use patterns in a very elderly population: a seven-year review. Clin Drug Investig 17(5):389–398CrossRef
go back to reference Gislason G, Abildstrom S, Rasmussen J, Rasmussen S, Buch P, Gustaffson I, Friberg J, Gadsböll N, Köber L, Stender S, Madsen M, Torp-Pedersen C (2005) Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002. Scand Cardiovasc J 39:42–49CrossRef Gislason G, Abildstrom S, Rasmussen J, Rasmussen S, Buch P, Gustaffson I, Friberg J, Gadsböll N, Köber L, Stender S, Madsen M, Torp-Pedersen C (2005) Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002. Scand Cardiovasc J 39:42–49CrossRef
go back to reference Gissler M, Haukka J (2004) Finnish health and social welfare registers in epidemiological research. Norsk Epidemiol 14(1):113–120 Gissler M, Haukka J (2004) Finnish health and social welfare registers in epidemiological research. Norsk Epidemiol 14(1):113–120
go back to reference Haider SI, Johnell K, Thorslund M, Fastbom J (2007) Trends in polypharmacy and potential drug–drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 45(12):643–653CrossRef Haider SI, Johnell K, Thorslund M, Fastbom J (2007) Trends in polypharmacy and potential drug–drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 45(12):643–653CrossRef
go back to reference Hajjar E, Cafiero A, Hanlon J (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345–351CrossRef Hajjar E, Cafiero A, Hanlon J (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345–351CrossRef
go back to reference Holmes H, Hayles D, Alexander G, Sachs G (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166(Mar27):605–609CrossRef Holmes H, Hayles D, Alexander G, Sachs G (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166(Mar27):605–609CrossRef
go back to reference Hoover D, Crystal S, Kumar R, Sambamoorthi U, Cantor J (2002) Medical expenditures during the last year of life: findings from the 1992–1996 Medicare current beneficiary survey. Health Serv Res 37(6):1625–1642CrossRef Hoover D, Crystal S, Kumar R, Sambamoorthi U, Cantor J (2002) Medical expenditures during the last year of life: findings from the 1992–1996 Medicare current beneficiary survey. Health Serv Res 37(6):1625–1642CrossRef
go back to reference Hovstadius B, Hovstadius K, Åstrand B, Petersson G (2010) Increased polypharmacy—an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 10:16CrossRef Hovstadius B, Hovstadius K, Åstrand B, Petersson G (2010) Increased polypharmacy—an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 10:16CrossRef
go back to reference Johnell K, Fastbom J (2012) Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging 29:751–758CrossRef Johnell K, Fastbom J (2012) Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs Aging 29:751–758CrossRef
go back to reference Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H (2006) Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75 + Study. Eur J Clin Pharmacol 62:151–158CrossRef Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H (2006) Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75 + Study. Eur J Clin Pharmacol 62:151–158CrossRef
go back to reference Lane C, Bronskill S, Sykora K, Dhalla I, Anderson G, Mamdani M, Gill S, Gurwitz J, Rochon P (2004) Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 52:861–866CrossRef Lane C, Bronskill S, Sykora K, Dhalla I, Anderson G, Mamdani M, Gill S, Gurwitz J, Rochon P (2004) Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 52:861–866CrossRef
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R (2002) Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809–817CrossRef Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R (2002) Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55:809–817CrossRef
go back to reference Lunney J, Lynn J, Foley D, Lipson S, Curalnik J (2007) Patterns of functional decline at the end of life. JAMA 289(18):2387–2392CrossRef Lunney J, Lynn J, Foley D, Lipson S, Curalnik J (2007) Patterns of functional decline at the end of life. JAMA 289(18):2387–2392CrossRef
go back to reference Maddison A, Fisher J, Johnston G (2011) Preventive medication use among persons with limited life expectancy. Prog Palliat Care 19(1):15–21CrossRef Maddison A, Fisher J, Johnston G (2011) Preventive medication use among persons with limited life expectancy. Prog Palliat Care 19(1):15–21CrossRef
go back to reference McNeil M, Kamal A, Kutner J, Ritchie C, Abernethy A (2016) The burden of polypharmacy in patients near end of life. J Pain Symptom Manage 51(2):178–183CrossRef McNeil M, Kamal A, Kutner J, Ritchie C, Abernethy A (2016) The burden of polypharmacy in patients near end of life. J Pain Symptom Manage 51(2):178–183CrossRef
go back to reference Menec V, Lix L, Nowicki S, Ekuma O (2007) Health care use at the end of life among older adults: does it vary by age? J Gerontol Med Sci 62A(4):400–407CrossRef Menec V, Lix L, Nowicki S, Ekuma O (2007) Health care use at the end of life among older adults: does it vary by age? J Gerontol Med Sci 62A(4):400–407CrossRef
go back to reference Mizokami F, Koide Y, Noro T, Furuta K (2012) Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother 10(2):123–128CrossRef Mizokami F, Koide Y, Noro T, Furuta K (2012) Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother 10(2):123–128CrossRef
go back to reference Morin L, Vetrano D, Rizzuto D, Calderón-Larranaga A, Fastbom J, Johnell K (2017) Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study. Am J Med 130(8):927–936CrossRef Morin L, Vetrano D, Rizzuto D, Calderón-Larranaga A, Fastbom J, Johnell K (2017) Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study. Am J Med 130(8):927–936CrossRef
go back to reference Mortazavi S, Shati M, Keshtkar A, Malakouti S, Bazargan M, Assari S (2016) Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open 6:e010989CrossRef Mortazavi S, Shati M, Keshtkar A, Malakouti S, Bazargan M, Assari S (2016) Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open 6:e010989CrossRef
go back to reference Murphy M, Martikainen P (2013) Use of hospital and long-term institutional care services in relation to proximity to death among older people in Finland. Soc Sci Med 88:39–47CrossRef Murphy M, Martikainen P (2013) Use of hospital and long-term institutional care services in relation to proximity to death among older people in Finland. Soc Sci Med 88:39–47CrossRef
go back to reference Paque K, Vander Stichele R, Elseviers M, Pardon K, Dilles T, Deliens L, Christiaens T (2019a) Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med 33(1):37–48CrossRef Paque K, Vander Stichele R, Elseviers M, Pardon K, Dilles T, Deliens L, Christiaens T (2019a) Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med 33(1):37–48CrossRef
go back to reference Paque K, De Schreye R, Elseviers M, Vander Stichele R, Pardon K, Dilles T, Christiaens T, Deliens L (2019b) Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Pharmacol 85:827–837CrossRef Paque K, De Schreye R, Elseviers M, Vander Stichele R, Pardon K, Dilles T, Christiaens T, Deliens L (2019b) Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Pharmacol 85:827–837CrossRef
go back to reference Pokela N, Bell S, Lihavainen K, Sulkava R, Hartikainen S (2010) Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharmacother 16:233–244CrossRef Pokela N, Bell S, Lihavainen K, Sulkava R, Hartikainen S (2010) Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharmacother 16:233–244CrossRef
go back to reference Pot A, Portrait F, Visser G, Puts M, Broese van Groenou M, Deeg D (2009) Utilization of acute and long-term care in the last year of life: comparison with survivors in a population-based study. BMC Health Serv Res 9:139CrossRef Pot A, Portrait F, Visser G, Puts M, Broese van Groenou M, Deeg D (2009) Utilization of acute and long-term care in the last year of life: comparison with survivors in a population-based study. BMC Health Serv Res 9:139CrossRef
go back to reference Rollason V, Vogt N (2003) Reduction of polypharmacy in the elderly. Drugs Aging 20(11):817–832CrossRef Rollason V, Vogt N (2003) Reduction of polypharmacy in the elderly. Drugs Aging 20(11):817–832CrossRef
go back to reference Wastesson J, Parker M, Fastbom J, Thorslund M, Johnell K (2012) Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age Ageing 4:218–224CrossRef Wastesson J, Parker M, Fastbom J, Thorslund M, Johnell K (2012) Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age Ageing 4:218–224CrossRef
Metadata
Title
Purchases of medicines among community-dwelling older people: comparing people in the last 2 years of life and those who lived at least 2 years longer
Authors
Jutta Pulkki
Mari Aaltonen
Jani Raitanen
Pekka Rissanen
Marja Jylhä
Leena Forma
Publication date
01-09-2020
Publisher
Springer Netherlands
Published in
European Journal of Ageing / Issue 3/2020
Print ISSN: 1613-9372
Electronic ISSN: 1613-9380
DOI
https://doi.org/10.1007/s10433-019-00543-9

Other articles of this Issue 3/2020

European Journal of Ageing 3/2020 Go to the issue